Tag | Content |
---|
EnhancerAtlas ID | HS092-33128 |
Organism | Homo sapiens |
Tissue/cell | HFF |
Coordinate | chr6:26304350-26306840 |
Target genes | Number: 25 | Name | Ensembl ID |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOS | MA0476.1 | chr6:26306601-26306612 | TCTGACTCATT | + | 6.32 | IRF9 | MA0653.1 | chr6:26305153-26305168 | AGCGAAACCAAAACT | + | 6.3 | Nfe2l2 | MA0150.2 | chr6:26306675-26306690 | CCCCATGACTTAGCA | + | 6 | RREB1 | MA0073.1 | chr6:26304977-26304997 | AGGTTGGGGTTGTGGGGGGG | - | 6.69 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_13464 | chr6:26303101-26306382 | CD34_Primary_RO01536 | SE_39857 | chr6:26302910-26306386 | K562 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr6 | 26306545 | 26306721 | chr6 | 26304496 | 26304842 | chr6 | 26305200 | 26306200 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH06I026303 | chr6 | 26303567 | 26306381 |
|
Enhancer Sequence | CAGCCTATTC TCTCACTTTC TAGATAAAAA TTATTAGGAT ATACAATCAC AAAATTACGG 60 TCAGCTAATG GTTCACCATG GCATTTTGTC TCCCTCTTTG CAACAAACCA ACAAATCCAA 120 TTTTGCTTGT CTACAGGTGT GTCTCTGGTG GTCTTTGTCA GGAATTTACC AACAGTCTTG 180 AATTCTGAAA CATTAAACAT CACAGACATA GAGGCAGCTA ACTTTTATGT AACACCTCCC 240 CTTTGTCCAC CACTAAACCA GATTAAGGGG AGATGTGTTA AACGTGGAAG ACAACAGAGC 300 CTCTGATAAA CCACATGAAT AAAAAAAAAA AAAGAAAGAT TTTTTTTTAA GTTGAAAAGT 360 TTTGCATGGC ATAAGCATAA CCAATTTTTC ATGTTTTTTG TTTAGATATG GGATGTTTAG 420 ATATGGGCCA AATGGCAGTT TCAAATATTT ATTTAGCAAG TTTAGCAGTC TTTTTTGTGT 480 GTGATTTTTA TATAACATAA ATTTTAATGG TCCTGTGGGC TTCATTATTT AGGAATGACA 540 TAGCATATGT AACCAATTCC TTTTTTCTTT CTTTCTCTCT CTCTCTTTTG TTTTTGTTTT 600 TGTTTTTGTT TTTGTTTTAA TGCGGGGAGG TTGGGGTTGT GGGGGGGTGG CGGTCTTGAT 660 ATATTGCTCA GGTTGGTCTC GAACTCCTGG ACTCAAGTGA TCCTCCAGTC TCAACCTTCC 720 AAAGTGCAAG GATTGCAGGC GTGTGCCACT GCGCCAGGCC CAATTCCTTA TGATTACACA 780 TTCATGATGA AAACTGCCGA AACAGCGAAA CCAAAACTAA GAAGGAAGTG AGGACAGTGA 840 TGGTTCTTAA CCCGGGAGAC CCAAGGCACT TGCAAAACGA CCACTAGACT CCACCCCTCT 900 AAAGATTTCG ATTTAACTGG TTCTAGGGGA GAGGAGGAGA CACGAGCATT TTGAGAAATC 960 TCCCCAGTTA TGTATAATTA ACAACCACCG GATCACAGCT AGATAAGGAG AAATGCTAGG 1020 CGCTACTCAG GGGGTTAAGC AAAAAATCAG AGGGTCGGAA ATCAGTTTTC AACTACAAGA 1080 GTCTTGCGGA TCTGGAGCAG CGGTGGATAC ACCTCTGCCT GCGCGGAGGG AGCGGAGCTA 1140 AAATACTGTA ATTTTTCGGA CCTTTATAAA ATAGAATCAG TAATCATGTT ACCAACAGAA 1200 GGTTGTTAGT GCCAGCACAC GTTAGTGTGC TAATACATAC TGAAGAATAC CTCTCTTAAA 1260 GGGAGCTAAA AACACCTAAT TCTCAGTGAG CAAACGGGGA GGTATAGCAG ACGATACCTT 1320 ACTGAGGGGA AACCTTTAAA AAAGCCCAGT TAGCAGGGAA AGCCGAGCGA CGAGGATGGG 1380 ATTCGAACCC ACGCGTGCAG AGCACAATGG ATTAGCAGTC CATCGCCTTA ACCACTCGGC 1440 CAGGCCTCTC CTGATATGTG TAATGTTTCT CTTCTCAACA GTTTCATTTG GCAATTCCTA 1500 TTCTTTTGTT AAATGTTTTC AGTGACGGAA ATAATGGATA AATGGCCCTC TTACTCTCAT 1560 AAAGGAAGAA AAACTAAAGA GGAGACTGGG AGGGAGGAAT AGACCCTAAT AAAGATGACA 1620 AAGTACACTT TCTAAGGGAA AAATAAGAGA AATTAAAAAG GAAAAACGAA TTAGTGACTG 1680 CTCCTGTTTT TTAAATCAAA TTGGATTTTG TCTTTTTTCT TAGGTCATGT ATATGAACAC 1740 CATCATTAAA CCAGGTATGT CTGTTGTTGC ATTCCTGGAC ACTCCCTGGT AGGATTCCCA 1800 GAGGGATGCC TGCCATATGA TGGCACTAAC GCATCTGAGA AATAACCATT GTCTCTCCTA 1860 GAAGCCCAAG TGGGTGACTG GTAAAGTGTT GAAGTGATGG GTTACAGTCA AATTGTGATT 1920 GGTTCTGAGT GTCAGACCCT AGAGTTTGGA CTGTATCTTA AAGAATCGTG GGGCCATCTG 1980 AGGGATTTTT GTTTTGTTTT TGCTTATTTT GCACAAAGAA ATGTGATGAA AATGATACTT 2040 AGTGTTGTCA TTTTTATTAT CTGTTTGTAT TTCATTTAAA TTCTAAATTA AAAAAATAAA 2100 TTTATTTTTA TAGAGACAGG GTCTCACTAT GTCACTCTGT TGCACAGGCT AGCCTCAAAC 2160 TCCTAGGCTC AAGCAATCCA CCCACCTTGG TTTACCCAAA GTACTGGGAT TACAGGCATG 2220 AGCCACCATG TCCAACCTTT CTTTGGTTGT TTCTGACTCA TTTCATCACA ATCAGAGAAG 2280 TCAGTCTGAT GCTAATGTTC TGTGAAATTA GGCAAAACAG AAGAACCCCA TGACTTAGCA 2340 GTGACTGCCT GGCCGATTCC TGACAATATG CAGGCCTAGT GAATACGGTC AGACCAGTTC 2400 CTGGATACCA GGGGCTGTTT TCTCACCTAT ACCCAATAAA ATTACAAAAA CAATAATATT 2460 GTGTATGTGT GTGTTTTGAC ATGATGTAGC 2490
|